Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Vasconcelos

Showing results (91-100 of 125) with videos related to

Pageof 13
Sort By:
Arthritis Research & Therapy|November 18, 2022
Accrual of organ damage in Behçet's syndrome: trajectory, associated factors, and impact on patients' quality of life over a 2-year prospective follow-up studyAlberto Floris, Matteo Piga, Riccardo Laconi, et al.
Rheumatology (Oxford, England)|December 13, 2023
Organ damage is a major determinant of work productivity impairment in Behçet's syndrome: a post hoc analysis of the BODI validation studyAlberto Floris, Riccardo Laconi, Gerard Espinosa, et al.
Annals of the Rheumatic Diseases|March 12, 2015
Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritisFarah Tamirou, David D'Cruz, Shirish Sangle, et al.
Frontiers in Immunology|May 4, 2023
Biological therapy in systemic lupus erythematosus, antiphospholipid syndrome, and Sjögren's syndrome: evidence- and practice-based guidanceAntónio Marinho, José Delgado Alves, Jorge Fortuna, et al.
Autoimmunity Reviews|May 25, 2023
Biologic therapy in large and small vessels vasculitis, and Behçet's disease: Evidence- and practice-based guidanceJoão Araújo Correia, Jorge Crespo, Glória Alves, et al.
Journal of Immunology Research|November 26, 2015
The Protective Role of HLA-DRB1(∗)13 in Autoimmune DiseasesAndreia Bettencourt, Cláudia Carvalho, Bárbara Leal, et al.
Annals of the Rheumatic Diseases|February 19, 2024
Molecular characterisation of lupus low disease activity state (LLDAS) and DORIS remission by whole-blood transcriptome-based pathways in a pan-European systemic lupus erythematosus cohortIoannis Parodis, Julius Lindblom, Guillermo Barturen, et al.
Arthritis Research & Therapy|November 26, 2020
Discordance between patient and physician global assessment of disease activity in Behçet's syndrome: a multicenter study cohortAlberto Floris, Gerard Espinosa, Luisa Serpa Pinto, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 21, 2021
Protein Mannosylation as a Diagnostic and Prognostic Biomarker of Lupus Nephritis: An Unusual Glycan Neoepitope in Systemic Lupus ErythematosusInês Alves, Beatriz Santos-Pereira, Hans Dalebout, et al.
The Journal of Infection|May 15, 2026
Lymph node remodelling underlies the attenuated form of HIV/AIDS in people with HIV-2Susana M Fernandes, Guilherme B Farias, Ana R Pires, et al.
Pageof 13

Showing results (91-100 of 125) with videos related to

Sort By:
Pageof 13
Arthritis Research & Therapy|November 18, 2022
Accrual of organ damage in Behçet's syndrome: trajectory, associated factors, and impact on patients' quality of life over a 2-year prospective follow-up studyAlberto Floris, Matteo Piga, Riccardo Laconi, et al.
Rheumatology (Oxford, England)|December 13, 2023
Organ damage is a major determinant of work productivity impairment in Behçet's syndrome: a post hoc analysis of the BODI validation studyAlberto Floris, Riccardo Laconi, Gerard Espinosa, et al.
Annals of the Rheumatic Diseases|March 12, 2015
Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritisFarah Tamirou, David D'Cruz, Shirish Sangle, et al.
Frontiers in Immunology|May 4, 2023
Biological therapy in systemic lupus erythematosus, antiphospholipid syndrome, and Sjögren's syndrome: evidence- and practice-based guidanceAntónio Marinho, José Delgado Alves, Jorge Fortuna, et al.
Autoimmunity Reviews|May 25, 2023
Biologic therapy in large and small vessels vasculitis, and Behçet's disease: Evidence- and practice-based guidanceJoão Araújo Correia, Jorge Crespo, Glória Alves, et al.
Journal of Immunology Research|November 26, 2015
The Protective Role of HLA-DRB1(∗)13 in Autoimmune DiseasesAndreia Bettencourt, Cláudia Carvalho, Bárbara Leal, et al.
Annals of the Rheumatic Diseases|February 19, 2024
Molecular characterisation of lupus low disease activity state (LLDAS) and DORIS remission by whole-blood transcriptome-based pathways in a pan-European systemic lupus erythematosus cohortIoannis Parodis, Julius Lindblom, Guillermo Barturen, et al.
Arthritis Research & Therapy|November 26, 2020
Discordance between patient and physician global assessment of disease activity in Behçet's syndrome: a multicenter study cohortAlberto Floris, Gerard Espinosa, Luisa Serpa Pinto, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 21, 2021
Protein Mannosylation as a Diagnostic and Prognostic Biomarker of Lupus Nephritis: An Unusual Glycan Neoepitope in Systemic Lupus ErythematosusInês Alves, Beatriz Santos-Pereira, Hans Dalebout, et al.
The Journal of Infection|May 15, 2026
Lymph node remodelling underlies the attenuated form of HIV/AIDS in people with HIV-2Susana M Fernandes, Guilherme B Farias, Ana R Pires, et al.
Pageof 13